Combined company to operate as Treeline Biosciences, advancing a deep pipeline of small molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates Company to be led by Treeline CEO and co-founder Josh Bilenker, MD, and experienced team of proven drug developers Treeline’s pipeline includes three Phase 1 programs with multiple anticipated clinical data readouts beginning in 2027 Well capitalized with over $900 million in cash expected […]
SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology NEW YORK — SOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint venture between the two […]
LONDON — SMi Systems announces today the execution of a non-exclusive evaluation collaboration with Luminex Corporation to assess the feasibility of using Luminex beads with SMi’s single-molecule imaging platform and to compare SMi’s analytical sensitivity with Luminex’s current xMAP readers under defined test conditions. The evaluation is initially focused on research activities to validate the potential […]
New genomic services portfolio establishes Zymo as a premier NGS partner, offering end-to-end solutions built on proven technology and deep scientific expertise IRVINE, Calif. — Zymo Research, a global leader in genomics tools, today announced the launch of Zymo Services, a dedicated portfolio of end-to-end next-generation sequencing (NGS) services. The new offering reflects Zymo’s evolution from molecular biology […]
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples BOULDER, Colo. —Integrated DNA Technologies (IDT), a Danaher […]
Shimadzu Corporation and Shimadzu Scientific Instruments (SSI) announce they have joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a public–private partnership dedicated to advancing biopharmaceutical manufacturing technologies in the United States. Through participation in NIIMBL, SSI, the North American subsidiary of Shimadzu Corporation’s Analytical and Measuring Instruments Division, will engage in collaborative projects […]
Compact, integrated electrophoresis solution enables fast, reliable DNA and RNA analysis without gel casting or buffer preparation Key facts Product: Invitrogen™ E-Gel™ Power Snap Lite Electrophoresis System Category: Nucleic acid gel electrophoresis system Key benefit: Rapid, simplified nucleic acid verification in a compact, all-in-one system Additional benefits: Eliminates the need for gel casting and buffer preparation Integrates gel […]
Leading life sciences investors ARCH Venture Partners, F-Prime Capital, and Primer Ventures fuel company’s expansion into cell and gene therapy, oncology, and molecular diagnostics PALO ALTO, Calif.– Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, today announced the closing of an oversubscribed $26 million financing round […]
Automating library prep reduces hands-on time for customers using Pillar Biosciences oncoReveal® targeted oncology research panels SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) and SPT Labtech today introduced the fireflyGO automation platform, a new benchtop liquid handling and library preparation solution that brings automation, speed, and simplicity to targeted oncology research. Integrated with the MiSeq™ i100 […]
An advanced research workflow for fast, flexible detection of molecular residual disease during and following treatment Solution is the first in a new WGS oncology portfolio, building on Illumina’s history of leadership as foundation for MRD market SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced a new complete solution for molecular residual disease (MRD) research […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
